2.800

+0.030 (+1.08%)
Range 2.770 - 2.820   (1.81%)
Open 2.800
Previous Close 2.770
Buy Price 2.780
Buy Volume 18
Sell Price 2.800
Sell Volume 8
Volume 7,807
Value -
Remark
Measurement Type Value
EPS (USD) -2.324
Trailing EPS (USD) -1.82
NAV (USD) 3.814
Cash In Hand (USD) 3.804
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 0.755
Price / Cash In Hand 0.757
Issued & Paid-up Shares 32,173,800
Treasury Shares 200,601
Market Cap (M) 92.661
Par Value (USD) n.a.
Beta - 75 Days 0.854
R-Squared - 75 Days(%) 5.2
Beta - 500 Days 0.82
R-Squared - 500 Days(%) 9.41
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 19 Oct 2021 23:16.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date 04 Nov 2021
View All Events

About CONCERT PHARMACEUTICALS INC

Concert Pharmaceuticals Inc is a United States-based company that is engaged in the pharmaceutical preparation and research industry. The Company is a clinical stage biotechnology company focused on applying the Company's DCE Platform (deuterated chemical entity platform) to create differentiated small molecule drugs. The Company tests and produces pharmaceutical drugs by utilizing the element deuterium. Its drug candidates address various therapeutic areas, including hot flashes, HIV, renal hepatic, neuropathic pain, MRSA infection, schizophrenia, multiple tumors, and hyperparathyroidism.

Loading Chart...